Scil Proteins is a biopharmaceutical company whose key value driver is its proprietary
Affilin® drug discovery platform. Scil Proteins has longstanding expertise in protein manufacturing, and their certified
GMP production facility generates revenue through long-term customer contracts.
Latest news:
23.06.2010:
Scil Proteins Pharma has
achieved validation of its proprietary Affilin® drug
discovery
platform in animals. The lead
product, SPVF 2801, an Affilin®
molecule for applications in solid tumors passed initial preclinical
studies
with excellent results. Read more...
